(Bloomberg) — Walgreens Boots Alliance Inc. will close 200 of its 8,232 U.S. drugstores to reduce costs as its profits get squeezed by competition and by lower reimbursements from pharmaceutical insurers.
The company will also reorganize corporate and field operations and revamp its technology, which along with the store closings will help cut an additional $500 million in costs by the end of fiscal 2017. That would extend a $1 billion cost-cutting initiative announced in August.
Investors cheered the plans and the company's quarterly earnings report, which beat analysts' estimates. Walgreens Boots shares climbed 3 percent to $90.30 in early trading. Through Wednesday, they had increased 15 percent this year.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
